Glaxosmithkline Pharmaceuticals fell 1.75% to Rs 1,489.15 after the company s consolidated net profit tanked 89.6% to Rs 14.33 crore on 4.9% increase in net sales to Rs 813.75 crore in Q4 March 2021 over Q4 March 2020.
Profit before tax (PBT) dropped 64.3% to Rs 63.01 crore in Q4 FY21 from Rs 176.55 crore in Q4 FY20. The Q4 result was declared post market hours yesterday, 18 May 2021.
On a standalone basis, revenue for the quarter came in at Rs 807 crore, recording an underlying growth of 6%. Total income came in at Rs 837 crore as compared to Rs 791 crore for the quarter ended 31st March 2020. PBT (before exceptional) for the quarter at Rs 180 crore, recorded a growth of 9%.
GSK Pharma Q4 FY21 Results: GSK Pharma Net Profit Falls 90% To Rs 14 Crore In January-March Quarter
ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.
GSK Pharma posts 6 pc growth in Q4 revenue at Rs 807 crore
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.